Director Noel R. Holland of Columbia Financial, Inc./MD/ filed a Form 4 on August 11, 2026, disclosing a non-derivative securities acquisition in common stock dated August 7, 2026, on NASDAQ:CLBK.

Key Highlights

  • Transaction date: August 7, 2026, with 15.7214 shares of common stock acquired at a price of $10.84 per share.
  • Acquisition type: The shares were purchased on a non-discretionary basis by the trustee of the Bank's rabbi trust under the Columbia Bank Stock Based Deferral Plan.
  • Post-transaction indirect holdings via deferral plan: 29,690.2255 shares beneficially owned following the reported transaction, held indirectly through the Stock-Based Deferral Plan.
  • Additional beneficial ownership: 80,797 shares held directly; 109,316 shares held indirectly through a SEP-IRA; and 6,494 shares held indirectly through Stock Award V, which vests on March 12, 2027.
  • Stock options: 183,246 fully vested stock options (right to buy) with an exercise price of $7.10, expiring July 23, 2029, held directly.

Holland's Beneficial Ownership Position at Columbia Financial Following August 2026 Transaction

According to the filing, director Noel R. Holland acquired 15.7214 shares of Columbia Financial, Inc./MD/ common stock on August 7, 2026, at a price of $10.84 per share. The filing states that this acquisition represents phantom stock purchased on a non-discretionary basis by the trustee of the Bank's rabbi trust maintained in connection with the Columbia Bank Stock Based Deferral Plan, a non-qualified stock-based deferral plan. The filing notes that stock unit interests under this plan will be settled in shares of stock upon distribution to the reporting person.

Following the reported transaction, Holland's indirect beneficial ownership through the Stock-Based Deferral Plan stood at 29,690.2255 shares. The filing also reports 80,797 shares held directly, 109,316 shares held indirectly through a SEP-IRA, and 6,494 shares held indirectly through a stock award granted under the Columbia Financial, Inc. 2019 Equity Incentive Plan, which the filing states vest in one year on March 12, 2027.

In Table II, the filing discloses 183,246 stock options (right to buy) with a conversion or exercise price of $7.10, with an expiration date of July 23, 2029. The filing states these options were granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan and are fully vested and exercisable. The Form 4 was signed by Thomas F. Splaine, Jr., as Power of Attorney, on August 11, 2026.

What Was Disclosed

Director Noel R. Holland disclosed the acquisition of 15.7214 shares of Columbia Financial common stock at $10.84 per share on August 7, 2026, through a non-discretionary rabbi trust purchase, along with a full summary of his beneficial ownership positions in direct and indirect securities.